Pharmacy Law

/Pharmacy Law

FisherBroyles Welcomes Health & Pharmacy Law Partner Janna King in Houston

HOUSTON — January 2, 2019 — FisherBroyles, LLP, the first and world’s largest cloud-based law firm partnership, is pleased to announce the addition of Janna King as a partner in the firm’s Houston office and Health & Pharmacy Law practice group. “We are thrilled to welcome Janna to FisherBroyles in our Houston office,” said FisherBroyles’ [...]

Government Achieves Another Round of Convictions in New England Compounding Center Case

In 2012, a nationwide meningitis outbreak caused by contaminated steroids killed 64 people and sickened nearly 800 others. Last week in a federal courthouse in Boston, an owner of the company that started it all, New England Compounding Center (NECC), along with four other employees, were convicted of numerous federal crimes for their roles in [...]

Client Alert – CMS Rule Change Could Cost Medicare Advantage Plans Billions

The Centers for Medicare & Medicaid Services (CMS) has proposed significant rule changes that could potentially cost insurers billions of dollars as CMS takes steps to recover what it contends are improper payments made to Medicare Advantage Organizations (MAOs). In a statement, CMS states that, “the proposed rule would strengthen CMS’s ability to return dollars [...]

RXinsider Thought Leader Videos – What are the risks and consequences of non-compliant data breaches?

As part of a Thought Leader Video Series, Anthony Calamunci and Brian Dickerson were interviewed by RXinsider on the status of the Pharmacy industry.  Each week FisherBroyles has provided access to the industry specific Q&A interview sessions hosted by RXinsider so you can learn what the newest legal and industry issues are and how to [...]

RXinsider Thought Leader Videos – What is the Current State of the Federal Investigation Landscape?

As part of a Thought Leader Video Series, Anthony Calamunci and Brian Dickerson were interviewed by RXinsider on the status of the Pharmacy industry.  Each week FisherBroyles will provide access to the industry specific Q&A interview sessions hosted by RXinsider so you can learn what the newest legal and industry issues are and how to [...]

RXinsider Thought Leader Videos – What is the Relationship between the Patient and the Prescriber?

  As part of a Thought Leader Video Series, Anthony Calamunci and Brian Dickerson were interviewed by RXinsider on the status of the Pharmacy industry.  Each week FisherBroyles will provide access to the industry specific Q&A interview sessions hosted by RXinsider so you can learn what the newest legal and industry issues are and how [...]

Client Alert – DaVita Agrees to Another Significant Settlement Amid Allegations of FCA Violations

Late last year we reported that DaVita Rx, a pharmacy unit of DaVita, Inc., (DaVita) one of the leading providers of dialysis services in the United States, agreed to pay a total of $63.7 million to resolve False Claims Act (FCA) allegations (“False Claims Settlement Costs DaVita Rx $63.7 Million”). Today, another one of its [...]

RXinsider Thought Leader Videos – What are Best Practices When Modifying PBM Agreements?

As part of a Thought Leader Video Series, Anthony Calamunci and Brian Dickerson were interviewed by RXinsider on the status of the Pharmacy industry.  Each week FisherBroyles will provide access to the industry specific Q&A interview sessions hosted by RXinsider so you can learn what the newest legal and industry issues are and how to [...]

Client Alert – AmeriSourceBergen Takes another Financial Hit for Fake Pharmacy Operation Under False Claims Act

In a recent announcement, the Department of Justice disclosed that AmerisourceBergen Corporation and several of its subsidiaries (collectively “ABC”) have agreed to pay $625 million in civil penalties to resolve False Claims Act allegations arising from its operation of a repackaging operation that ABC claimed was a pharmacy. The $625 million is on top of [...]

RXinsider Thought Leader Videos – What are the Implications of Receiving a Civil Investigative Demand (CID)?

As part of a Thought Leader Video Series, Anthony Calamunci and Brian Dickerson were interviewed by RXinsider on the status of the Pharmacy industry.  Each week FisherBroyles will provide access to the industry specific Q&A interview sessions hosted by RXinsider so you can learn what the newest legal and industry issues are and how to [...]